Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$29.75 - $37.99 $11.9 Million - $15.2 Million
-400,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$35.51 - $54.03 $14.2 Million - $21.6 Million
400,000 New
400,000 $16.6 Million

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $709M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Foresite Capital Management V, LLC Portfolio

Follow Foresite Capital Management V, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresite Capital Management V, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foresite Capital Management V, LLC with notifications on news.